Foot-and-Mouth Disease (FMD)

Foot-and-Mouth Disease (FMD) is an extremely contagious viral infection affecting cloven-hoofed animals, recognized as one of the most economically devastating livestock diseases in the world. Caused by a picornavirus with seven distinct serotypes and numerous subtypes, FMD produces characteristic vesicular lesions on the mouth, feet, and teats of affected animals. While mortality rates in adult animals are typically low, the disease causes severe production losses and triggers massive trade restrictions that make it among the most feared livestock diseases globally.

FMD affects all cloven-hoofed animals including cattle, sheep, goats, pigs, and numerous wildlife species, though clinical severity varies between species. Cattle typically display obvious clinical signs with vesicles in the mouth causing excessive salivation and drooling, and foot lesions causing severe lameness. Sheep and goats often experience milder clinical signs that may go undetected, potentially allowing silent spread through populations. Pigs are considered amplifier hosts, producing enormous quantities of virus in respiratory secretions while being highly susceptible to airborne infection.

The economic impact of FMD extends far beyond direct animal losses to encompass trade restrictions, control costs, and market disruptions affecting entire national economies. Countries maintaining FMD-free status face immediate suspension of livestock and livestock product exports following any outbreak detection, with restoration of trade often requiring years of demonstrated disease freedom. The 2001 United Kingdom outbreak resulted in the culling of over six million animals and economic losses estimated at eight billion pounds. Endemic FMD in developing countries causes ongoing production losses and limits access to premium export markets.

FMD is a reportable disease in virtually all countries, requiring immediate notification of veterinary authorities upon suspicion of disease. In FMD-free countries, control policies typically mandate stamping out through culling of affected and exposed animals, movement restrictions, and intensive surveillance. Treatment of affected animals is not permitted, as allowing recovery and potential carrier status would perpetuate infection. In endemic regions where eradication is not currently feasible, vaccination programs and supportive care reduce clinical impact while long-term control efforts continue. Any suspicion of FMD requires immediate veterinary consultation and regulatory notification.

Foot-and-Mouth Disease virus (FMDV) belongs to the Aphthovirus genus within the Picornaviridae family. This small, non-enveloped RNA virus exists as seven distinct serotypes designated O, A, C, SAT1, SAT2, SAT3, and Asia1, with numerous subtypes within each serotype demonstrating varying geographic distributions and virulence characteristics. The lack of cross-protection between serotypes means that infection or vaccination against one serotype provides no immunity against others, complicating control efforts in regions where multiple serotypes circulate.

The extraordinary contagiousness of FMDV relates to the virus's ability to spread through multiple routes and its low infectious dose. Direct contact between infected and susceptible animals provides efficient transmission through respiratory secretions, saliva, vesicular fluid, and other body fluids containing high viral concentrations. Airborne spread can occur over considerable distances under favorable meteorological conditions, with documented transmission over 60 kilometers across water in European outbreaks. Fomite transmission through contaminated vehicles, equipment, clothing, and feed represents a major dissemination route, particularly relevant for farm-to-farm spread.

Environmental and management factors significantly influence FMD transmission and outbreak dynamics. The virus survives in the environment for extended periods under cool, moist, shaded conditions but is rapidly inactivated by heat, desiccation, and pH extremes. Intensive livestock production systems with high animal densities facilitate rapid within-herd spread once infection is introduced. Movement of animals, including for breeding, fattening, and slaughter, creates opportunities for long-distance dissemination. Wildlife populations including deer, wild boar, and African buffalo can maintain infection and serve as sources for domestic livestock in some regions.

Risk factors for FMD introduction and spread include proximity to endemic regions, livestock importation from affected areas, and inadequate border controls on animal products. Within-country risk factors include intensive livestock production, frequent animal movements, shared equipment and facilities, and inadequate biosecurity practices. Countries with large populations of small-scale producers face challenges in disease detection and reporting that may allow initial spread before recognition. Illegal movement of animals and animal products poses ongoing risk even in regions with strong border controls.

FMD pathogenesis begins with viral entry through the respiratory or oral mucosa, followed by local replication and viremia distributing virus throughout the body. The virus demonstrates tropism for epithelial cells, particularly at sites of mechanical stress including the tongue, dental pad, lips, coronary band of the feet, and teats. Viral replication causes cell death and accumulation of fluid beneath the epithelium, producing the characteristic vesicles that rupture to leave painful erosions. Fever develops during the viremic phase before vesicle formation. Recovery occurs over two to three weeks in uncomplicated cases, though some animals, particularly cattle, may become persistent pharyngeal carriers harboring virus for months to years.

Early warning signs of FMD in cattle typically include sudden onset of fever reaching 104 to 106 degrees Fahrenheit, accompanied by depression and marked decrease in appetite. Affected animals may appear reluctant to move and show reduced rumination. Close observation may reveal excessive salivation even before visible mouth lesions develop. Dairy cattle often show abrupt decline in milk production that precedes other obvious signs by hours to a day. The incubation period from exposure to clinical signs is typically two to fourteen days, with most cases developing signs within three to five days.

The hallmark vesicular lesions of FMD develop progressively over the course of disease. Initial vesicles appear as raised, fluid-filled blisters ranging from small papules to large blebs several centimeters in diameter. In the mouth, vesicles form on the tongue, dental pad, lips, gums, and hard palate, causing intense pain that inhibits eating and drinking. Foot lesions develop at the coronary band, in the interdigital cleft, and on the heels, causing severe lameness. Teat lesions in lactating animals create milking difficulties and predispose to mastitis. Vesicles typically rupture within 24 to 48 hours, leaving raw, painful erosions.

Behavioral changes in FMD-affected cattle reflect the severe pain associated with oral and foot lesions. Affected animals stand apart from the herd, often with heads lowered and excessive drooling of saliva that may appear frothy or hang in strings from the mouth. The characteristic lip-smacking or chomping sound results from the discomfort of mouth lesions. Cattle are extremely reluctant to walk, often shifting weight between feet or lying down to avoid standing. When forced to move, affected animals display an exaggerated, stilted gait attempting to minimize pressure on painful feet.

Physical examination of FMD-suspect animals must be conducted with extreme care given the zoonotic potential and regulatory implications of this disease. Visual inspection from a distance reveals the depression, excessive salivation, and lameness characteristic of clinical disease. Closer examination of the mouth shows vesicles or erosions on the tongue, dental pad, gums, lips, and palate. Feet should be examined for vesicles at the coronary band, interdigital erosions, and separation of horn from underlying tissue. Rectal temperature is elevated during early disease. In lactating animals, examination of teats reveals vesicles or erosions creating irregular surfaces.

Symptom progression in uncomplicated FMD follows a predictable pattern over approximately two weeks. The febrile phase with initial vesicle formation lasts two to three days. Vesicles enlarge and rupture over the following one to three days, with maximum pain and disability during this period. Secondary bacterial infection of erosions may develop, particularly on feet exposed to environmental contamination. Healing begins after approximately one week, with epithelialization of erosions occurring over several additional days. Most adult cattle recover clinically within two to three weeks, though milk production may take longer to return to pre-infection levels.

Emergency symptoms and situations requiring immediate action include any suspicion of FMD in FMD-free countries, which constitutes a veterinary emergency requiring immediate regulatory notification. Multiple animals developing sudden fever, salivation, and lameness simultaneously suggests highly contagious disease requiring urgent investigation. High mortality in young calves, which may occur with certain FMD strains, indicates severe disease requiring attention. Any vesicular disease in pigs, which amplify virus tremendously, represents a critical concern for rapid spread.

Clinical examination of FMD-suspect animals follows strict protocols designed to confirm suspicion while preventing potential spread. Veterinarians conducting foreign animal disease investigations follow prescribed procedures including personal protective equipment use, sample collection techniques, and decontamination protocols. Clinical scoring systems evaluate the combination of fever, vesicular lesions in mouth and feet, salivation, and lameness that characterize FMD. The presence of vesicular disease affecting multiple animals simultaneously strongly suggests FMD or related vesicular diseases requiring laboratory differentiation.

Laboratory diagnosis of FMD employs multiple testing methods to confirm infection and characterize the viral strain. Vesicular fluid and epithelial samples from fresh lesions provide optimal material for virus isolation and detection. Enzyme-linked immunosorbent assays detect viral antigen in clinical samples within hours at approved laboratories. Reverse-transcriptase polymerase chain reaction identifies viral RNA with high sensitivity and enables serotype determination. Virus isolation in cell culture confirms viable virus and allows complete characterization. Serology detecting antibodies confirms exposure but cannot distinguish vaccination from infection without additional testing.

Differential diagnosis for vesicular disease in cattle includes several conditions requiring laboratory differentiation from FMD. Vesicular stomatitis virus causes clinically similar disease with mouth and foot lesions, occurring primarily in the Americas. Bovine viral diarrhea may produce oral erosions but typically lacks foot involvement. Chemical or thermal burns can cause oral lesions. Photosensitization may produce foot and muzzle lesions in white-skinned areas. Bluetongue causes oral erosions and coronary band lesions but with characteristic cyanotic coloration. None of these conditions produce the combination of fever, excessive salivation, vesicular lesions in mouth and on feet, and extreme contagiousness characteristic of FMD.

Surveillance and regulatory testing programs maintain FMD vigilance in free countries and monitor disease status in endemic regions. Active surveillance includes testing of animals at slaughter, investigation of disease reports meeting suspect criteria, and targeted sampling in high-risk populations. Serological surveys detect evidence of viral circulation even in absence of reported clinical disease. Import testing of animals and products from affected regions provides border protection. International reference laboratories provide confirmatory testing and strain characterization supporting global FMD intelligence. These programs enable rapid response when FMD is detected and demonstrate disease-free status supporting international trade.

Treatment of FMD is not permitted in most FMD-free countries, where control policy mandates stamping out through humane euthanasia of affected and exposed animals. This approach, while seemingly harsh, prevents establishment of endemic infection and preserves disease-free status essential for international trade. Veterinary authorities coordinate rapid culling of affected premises, with compensation programs helping offset producer losses. Movement restrictions contain infection within affected areas while surveillance identifies additional infected premises for action.

In endemic regions where eradication is not currently feasible, supportive care helps affected animals recover and return to production. Soft, palatable feeds encourage eating despite painful mouth lesions, with mashes, silages, and fresh grass being more acceptable than dry hay or coarse feeds. Fresh water should be readily available and accessible without requiring extensive walking. Anti-inflammatory drugs including non-steroidal anti-inflammatories reduce fever and pain, improving feed intake and welfare. Affected animals benefit from soft, clean bedding and housing that minimizes walking requirements.

Secondary bacterial infections commonly complicate FMD lesions, particularly on feet exposed to environmental contamination. Foot lesions may develop deep infections, underrunning of the sole, or separation of the hoof wall from underlying tissues. Antimicrobial therapy targeted at likely pathogens, including Fusobacterium necrophorum and other anaerobic bacteria, helps control these complications. Foot bathing with appropriate disinfectant solutions reduces bacterial contamination of healing lesions. Teat lesions predispose to mastitis requiring monitoring and treatment as needed.

Surgical intervention is occasionally required for severe FMD complications in endemic regions where treatment is permitted. Necrotic tissue debridement from foot lesions promotes healing and reduces ongoing infection risk. Hoof trimming addresses abnormal horn growth that may follow coronary band damage. In valuable animals, digit amputation may salvage animals with severe single-digit involvement. These interventions should be performed by veterinarians experienced in their application and with appropriate attention to welfare and prognosis.

Herd-level management during FMD outbreaks in endemic regions focuses on limiting spread while supporting recovery. Isolation of clinically affected animals reduces transmission to unaffected herdmates, though all animals on affected premises should be considered exposed. Disinfection of premises and equipment reduces environmental viral load. Movement restrictions prevent spread to other premises. Strategic vaccination may be employed to protect at-risk populations, though vaccine must match circulating serotypes for effectiveness. Record keeping documents affected animals for monitoring and management decisions.

Economic considerations heavily influence FMD management decisions at individual and policy levels. In free countries, the enormous trade consequences of endemic FMD justify aggressive stamping-out policies despite immediate losses. Endemic region producers weigh treatment costs against animal value and productive potential. Vaccination costs must be balanced against expected losses from clinical disease. International organizations provide technical and financial support for FMD control programs in endemic developing countries, recognizing both the economic and food security implications of this disease.

Recovery from FMD in regions where treatment is permitted typically occurs over two to four weeks, though return to full production may require longer periods. Fever resolves within a few days of onset as the immune response controls viremia. Oral lesions heal over approximately ten to fourteen days, with progressive epithelialization of erosions and return of normal feeding behavior. Foot lesions may take longer to heal completely, particularly if secondary bacterial infection has occurred. Salivation normalizes as mouth lesions heal, and affected animals gradually resume normal activity and social behavior.

Post-recovery monitoring must account for the carrier state that may develop in recovered cattle. Approximately fifty percent of cattle recovering from FMD become pharyngeal carriers, harboring virus in the oropharynx for periods ranging from weeks to over three years. Carrier animals do not show clinical signs and shed relatively small amounts of virus compared to acutely infected animals, but their potential role in maintaining and transmitting infection remains a concern. Testing can identify carrier animals through probang sampling of oropharyngeal fluid for viral RNA detection.

Prognosis for individual animals recovering from FMD is generally good for survival but variable for return to full production. Adult cattle typically survive with mortality rates of only one to five percent except in certain strain outbreaks affecting heart muscle. Young calves face higher mortality, with myocarditis causing sudden death in some outbreaks. Chronic foot complications including abnormal hoof growth, chronic lameness, and digital deformities may affect some recovered animals. Dairy cattle may experience persistent reduction in milk yield following recovery.

Return to production following FMD recovery requires attention to both individual animal recovery and regulatory requirements. In endemic regions, recovered animals may return to normal production activities once clinically recovered, though carrier status should be considered. Weight loss during illness requires nutritional rehabilitation before breeding or finishing cattle meet targets. Dairy cattle require gradual return to full milking routine as teat lesions heal. Regulatory requirements in countries conducting eradication programs may prohibit return to production regardless of clinical recovery.

Vaccination against FMD provides the primary preventive tool in endemic regions and serves as an emergency measure during outbreaks in some free countries. Inactivated vaccines containing multiple serotypes and subtypes relevant to regional epidemiology are administered according to schedules typically requiring primary vaccination followed by boosters at three to twelve month intervals depending on product and risk level. Vaccine strain must match circulating virus serotypes for effectiveness, necessitating ongoing surveillance and vaccine composition adjustment. High-potency emergency vaccines can provide protection within four to seven days for use during outbreak response.

Biosecurity measures form the cornerstone of FMD prevention in free countries and critical supplementary protection in endemic regions. Prevention of direct and indirect contact with infected animals or contaminated materials requires control of animal movements, visitor access, and material entry to premises. Vehicle and equipment disinfection prevents fomite transmission between farms. Personnel hygiene including clothing changes and hand disinfection reduces risk from human-mediated virus movement. Physical barriers and distance from neighboring livestock provide additional protection.

Border controls and import restrictions prevent introduction of FMD to free countries. Prohibition of imports of susceptible animals and animal products from affected regions represents the primary barrier. Inspection of baggage, vehicles, and cargo at ports of entry identifies smuggled materials. Heat treatment and other processing requirements for permitted imports reduce risk from animal products. International certification and verification systems support trade while maintaining disease security.

Management practices supporting FMD prevention address the various transmission pathways for this highly contagious virus. Closed herd management limiting outside animal introductions reduces introduction risk. Quarantine and testing of any necessary purchases before herd entry provides additional protection. Avoiding shared equipment, grazing areas, and water sources with cattle of unknown health status prevents indirect exposure. Staff training in recognition of FMD signs enables early detection that limits spread duration.

Surveillance and reporting systems enable early detection essential for limiting FMD spread when prevention fails. Producer and veterinarian education ensures recognition of suspect signs triggering investigation. Reporting systems provide rapid notification channels to veterinary authorities. Active surveillance programs sample populations for evidence of infection. International intelligence sharing alerts countries to regional disease events requiring enhanced vigilance. These systems must function continuously, as FMD introduction can occur at any time through numerous pathways.

Daily management in FMD-endemic regions incorporates disease awareness and monitoring into routine operations. Animals should be observed at least daily for signs of fever, salivation, lameness, or other abnormalities suggesting possible FMD or other health problems. Production monitoring including milk yields and weight gains may reveal subclinical effects before obvious clinical signs develop. Feed and water access should be verified to ensure affected animals can meet nutritional needs despite potential mouth or foot pain. Prompt investigation of any suspect animals limits spread duration and enables early intervention.

Housing and environmental management considerations for FMD include maintaining cleanliness to reduce secondary bacterial infection risk and facilitating observation and treatment of affected animals. Soft, clean bedding reduces pressure on painful feet and prevents wound contamination. Smooth, non-abrasive flooring minimizes additional foot trauma. Adequate shade and ventilation prevent heat stress that could exacerbate clinical signs. Water and feed should be easily accessible without requiring extensive walking. Isolation facilities for affected animals allow separation from susceptible herdmates.

Herd health programs in endemic regions should incorporate FMD vaccination as a core component. Vaccination schedules should be designed in consultation with veterinary authorities knowledgeable about regional epidemiology and circulating serotypes. Booster timing should be maintained consistently, as immunity may wane between vaccinations. Young animals require primary vaccination series at appropriate ages based on maternal antibody decline. Records of vaccination dates, products, and animals covered support program evaluation and regulatory compliance.

Record keeping for FMD management tracks vaccination status, disease events, and animal movements. Individual animal identification enables tracking of vaccination history and disease status. Group vaccination records document coverage levels and timing. Disease event records including clinical signs, affected animals, and outcomes inform management decisions and outbreak investigations. Movement records demonstrate compliance with any applicable restrictions and support tracing if disease occurs. These records may be required by regulatory authorities and support compensation claims if animals are culled.

Economic analysis of FMD management in endemic regions should account for vaccination costs, expected disease losses with and without vaccination, production impacts of clinical disease, and potential trade implications. Vaccination programs typically provide strong return on investment given the production losses associated with clinical FMD. Additional biosecurity investments may be justified for high-value operations or those seeking access to FMD-free markets. Emergency planning including contingency funds and insurance helps operations survive outbreak events.

All breeds of cattle are susceptible to FMD infection without significant breed-related resistance, though clinical severity may vary between breed types under different production conditions. European dairy breeds including Holstein, Jersey, and Brown Swiss experience typical clinical disease with vesicular lesions and production losses when infected. British beef breeds including Angus, Hereford, and Shorthorn show similar susceptibility. Continental beef breeds and various crosses demonstrate no meaningful breed-based protection against FMD.

Production system factors create varying FMD risk independent of breed. Intensive dairy operations with frequent movements, shared facilities, and high animal densities face elevated risk of introduction and rapid spread. Feedlot operations receiving cattle from multiple sources concentrate animals with varying exposure histories. Extensive beef operations may have lower introduction risk but face challenges in detecting early cases across dispersed animals. Smallholder operations with multiple species and limited biosecurity infrastructure represent significant risk in endemic regions.

Breed selection considerations related to FMD are minimal given the universal susceptibility of cattle. Selection for general disease resistance, robust immune function, and production under challenging conditions may provide marginal benefits in endemic regions. Local breeds adapted to regional conditions may maintain productivity better than imported genetics under endemic disease pressure. However, management factors including vaccination, biosecurity, and early detection far outweigh any breed-related factors in determining FMD outcomes.

Vesicular stomatitis represents the primary differential diagnosis for FMD in the Americas, producing clinically similar vesicular lesions affecting mouth, feet, and teats. This viral disease, transmitted by insect vectors and direct contact, occurs seasonally in southwestern North America and more continuously in Central and South America. Laboratory testing is essential to differentiate vesicular stomatitis from FMD given the dramatically different regulatory responses required. Unlike FMD, vesicular stomatitis has zoonotic potential, with infected humans developing flu-like illness.

Other vesicular diseases requiring differentiation from FMD include swine vesicular disease and vesicular exanthema of swine, both of which affect only pigs but require consideration in mixed-species investigations. Senecavirus A has emerged as a cause of vesicular disease in pigs in the Americas, adding to the differential diagnosis list. These diseases share the common feature of producing vesicular lesions that can only be definitively distinguished from FMD through laboratory testing.

Secondary conditions commonly associated with FMD include bacterial complications of lesions, particularly foot infections following environmental contamination of open erosions. Mastitis may develop secondary to teat lesions that disrupt normal teat structure and hygiene. Myocarditis occurs in some FMD outbreaks, particularly affecting young calves and causing sudden death or chronic heart failure. Chronic lameness and foot deformities may follow severe foot involvement with damage to the coronary band and hoof-producing structures.